KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Non-Current Deferred Tax Liability (2020 - 2025)

AbCellera Biologics filings provide 6 years of Non-Current Deferred Tax Liability readings, the most recent being $9.1 million for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 85.69% to $9.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Dec 2025, down 85.69% year-over-year, with the annual reading at $9.1 million for FY2025, 85.69% down from the prior year.
  • Non-Current Deferred Tax Liability hit $9.1 million in Q4 2025 for AbCellera Biologics, down from $9.7 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $77.2 million in Q4 2023 and bottomed at $9.1 million in Q4 2025.
  • Average Non-Current Deferred Tax Liability over 5 years is $31.9 million, with a median of $33.2 million recorded in 2023.
  • The largest annual shift saw Non-Current Deferred Tax Liability skyrocketed 65.54% in 2022 before it crashed 85.69% in 2025.
  • AbCellera Biologics' Non-Current Deferred Tax Liability stood at $37.4 million in 2021, then skyrocketed by 65.54% to $61.9 million in 2022, then rose by 24.65% to $77.2 million in 2023, then fell by 17.48% to $63.7 million in 2024, then crashed by 85.69% to $9.1 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Non-Current Deferred Tax Liability are $9.1 million (Q4 2025), $9.7 million (Q3 2025), and $10.1 million (Q2 2025).